Mannitol-based amphipathic compound and use thereof

Patent metadata

Field	Value
Publication number	US-10889609-B2
Application number	US-201515758782-A
Country	US
Kind code	B2
Filing date	Dec 14, 2015
Priority date	Sep 9, 2015
Publication date	Jan 12, 2021
Grant date	Jan 12, 2021

Abstract

The present invention relates to a mannitol-based amphipathic compound, a method of preparing the same, a method of extracting, solubilizing, stabilizing or crystallizing a membrane protein using the compound, and a method of analyzing a structure of the membrane protein under an electron microscope using the compound. When the mannitol-based compound according to the present invention is used, the membrane protein can be stably stored in an aqueous solution for a prolonged period of time and thus can be applied to analysis of functions and structures thereof. Since the analysis of the structures and functions of the membrane protein is one of the fields of most interest in biology and chemistry currently, and more than half of new drugs currently in development are targeting membrane proteins, the present invention is applicable to research on the structures of membrane proteins closely related to the development of the new drugs.

First claim

The invention claimed is:

1. A composition for extracting, solubilizing, stabilizing or crystallizing a membrane protein, or analyzing a structure of the membrane protein using an electron microscope, the composition comprising a compound represented by the following Formula 1:

wherein R 1 and R 2 are each independently an unsubstituted C 5 -C 20 alkyl group, a substituted or unsubstituted C 5 -C 20 cycloalkyl group, or a substituted or unsubstituted C 5 -C 20 aryl group; and
X 1 , X 2 , X 3 , and X 4 are each independently a glucose or maltose,
whereby the composition is for extracting, solubilizing, stabilizing or crystallizing a membrane protein, or analyzing the structure of the membrane protein using the electron microscope.

2. The composition of claim 1 , wherein each of R 1 and R 2 is C 7 -C 18 alkyl group; R 1 and R 2 are the same.

3. The composition of claim 1 , wherein the compound is represented by the following Formula 2, Formula 3, Formula 4, Formula 5, Formula 6, Formula 7, Formula 8, Formula 9, Formula 10, or Formula 11:

4. The composition of claim 1 , wherein the compound is an amphipathic molecule for extracting, solubilizing, stabilizing or crystallizing a membrane protein.

5. The composition of claim 1 , wherein the compound has a critical micellar concentration (CMC) of 1×10 −4 mM to 1.0 mM in an aqueous solution.

6. The composition of claim 1 , wherein the compound is an amphipathic molecule capable of forming a complex with the membrane protein for analyzing a structure of the membrane protein using an electron microscope.

7. The composition of claim 1 , wherein the composition is a micelle, a liposome, an emulsion, or a nanoparticle formulation.

Assignees

• Iucf Hyu Erica Campus

Inventors

• Chae Pil Seok
• Hussain Hazrat

Classifications

• C07C41/28

  from acetals, e.g. by dealcoholysis · CPC title

• C07K1/32

  as complexes · CPC title

• C07K1/14

  Extraction; Separation; Purification · CPC title

• G01N33/6872

  Intracellular protein regulatory factors and their receptors, e.g. including ion channels · CPC title

• C07H1/00

  Processes for the preparation of sugar derivatives · CPC title